I/ONTAK'spotentialmarket is>$300mI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022Mino-Lokis our leadassetMyron Holubiakand I founded aprivatecompany in2013We haveenough cashto go wellinto 2023I/ONTAKwas thebest deal Iever madeNot manycompaniesthis size with2 late stageassetsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Hemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamAn actualiMSCupdateI won't diluteshareholdersWe willhaveexclusivityWe had aphase 2btrial with100%efficacyWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfInsidersinvested$26.5mMino-WrapI/ONTAK'spotentialmarket is>$300mI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022Mino-Lokis our leadassetMyron Holubiakand I founded aprivatecompany in2013We haveenough cashto go wellinto 2023I/ONTAKwas thebest deal Iever madeNot manycompaniesthis size with2 late stageassetsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Hemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamAn actualiMSCupdateI won't diluteshareholdersWe willhaveexclusivityWe had aphase 2btrial with100%efficacyWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfInsidersinvested$26.5mMino-Wrap

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK's potential market is >$300m
  2. I/ONTAK is our lead asset
  3. Our Halo-Lido trial will have final patient by end of 2022
  4. Mino-Lok is our lead asset
  5. Myron Holubiak and I founded a private company in 2013
  6. We have enough cash to go well into 2023
  7. I/ONTAK was the best deal I ever made
  8. Not many companies this size with 2 late stage assets
  9. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  10. We expect to finish the Mino-Lok trial this year
  11. We intend to submit a BLA in 2H 2022
  12. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  13. Hemorrhoids is a $2B market
  14. There are no FDA approved drugs to treat hemorrhoids
  15. Mino-Lok potential market >$1B
  16. Only biotech with 2 Myron's on the leadership team
  17. An actual iMSC update
  18. I won't dilute shareholders
  19. We will have exclusivity
  20. We had a phase 2b trial with 100% efficacy
  21. We will open up international sites for Mino-Lok trial
  22. I'm a shareholder myself
  23. Insiders invested $26.5m
  24. Mino-Wrap